High levels of liver enzymes can suggest liver inflammation or disease. Liver enzyme tests can help diagnose issues like hepatitis, cirrhosis, and heart disease. Factors like alcohol use and physical ...

Doctors can diagnose fatty liver disease, now called metabolic dysfunction-associated steatotic liver disease (MASLD), using blood tests that measure serum liver enzyme levels. Elevated enzyme levels ...

Jay N. Yepuri, MD, MS, FACG, is a board-certified gastroenterologist and member of the Digestive Health Associates of Texas Board of Directors and Executive Committee. A liver function test checks how ...

An intelligent liver function test platform (iLFT) successfully integrated into one Scottish primary care system reduced unnecessary specialist referrals over a 5-year period, and improved triage for ...

Researchers have recently created a blood test that can detect liver disease years before symptoms ever develop, helping pave the way for the diagnosis of diseases such as cirrhosis and liver cancer ...

Yes, it is possible to have a normal liver function test if you have cirrhosis, but this is rare. Cirrhosis is a condition that causes scarring and damage of the liver, which can prevent it from ...

Noninvasive liver diagnostic devices are transforming the detection and management of liver disease. The leading device-based solutions showcase this innovative technology and offer numerous clinical ...

Hepatic steatosis is promoted by factors such as obesity, insulin resistance, de novo lipogenesis, high-calorie diets, genetic factors, and gut microbiome dysbiosis. In contrast, VLDL export, and ...

LFT slightly high. There is no pain. No yellowing of the eyes. No weakness. So it is easy to brush it aside. But the liver rarely shouts in the beginning. It whispers.Liver Function Tests, or LFTs, ...

A flat stomach and a healthy weight often feel like proof of good health. But doctors now warn of a quiet problem hiding behind many “normal” bodies: fatty liver disease. It happens when fat builds up ...

In a cohort study of nearly 16,000 US patients with breast cancer who were prescribed a cyclin-dependent kinase (CDK) 4/6 inhibitor, only 46% underwent liver function testing in the 2 weeks before ...